A much more widespread feature of prominent and relatively homogeneously expressed TAAs is their elevated expression in cancer cells compared to normal cells; examples abound, including CEA, STEAP1, CLDN6, ENPP3, MUC16, CD70, and DLL3. This evidence concerns the gene CEACAM5 and cancer.